SCHEMBL11301460

SCHEMBL11301460

CC(C)(c1ccccc1)N(c1ccc(C(=O)NO)cc1)C1CCNC1=O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 12/20 0.44
▸ HDAC6 Q9UBN7 12/20 0.43
▸ HDAC1 Q13547 10/20 0.41
▸ HDAC3 O15379 6/20 0.41
▸ HDAC2 Q92769 4/20 0.41
▸ HDAC11 Q96DB2 2/20 0.41
▸ HDAC7 Q8WUI4 2/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC10 Q969S8 1/20 0.41
▸ HDAC9 Q9UKV0 1/20 0.41
▸ HDAC5 Q9UQL6 1/20 0.41
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ NCOR2 Q9Y618 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11294960 0.95 HDAC8 (0.41) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11299511 0.78 HDAC8 (0.41) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11297375 0.76 HDAC8 (0.44) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11300775 0.76 HDAC1 (0.50) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11297519 0.75 HDAC6 (0.43) HDAC8HDAC6HDAC1
SCHEMBL11301466 0.74 HDAC1 (0.44) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11301463 0.74 HDAC6 (0.42) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11300469 0.74 HDAC6 (0.47) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11296174 0.73 HDAC8 (0.44) HDAC8HDAC6HDAC1HDAC3HDAC2
SCHEMBL11299163 0.72 HDAC6 (0.40) HDAC8HDAC6HDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback